Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Moderate Psoriasis”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)Study completedNCT04306315
What this trial is testing

Adjusted Brodalumab Dose Compared With Standard Brodalumab Dose in Subjects With Moderate-to-severe Plaque Psoriasis and ≥120 kg Body Weight

Who this might be right for
Psoriasis Vulgaris
LEO Pharma 385
Early research (Phase 1)Study completedNCT02303509
What this trial is testing

Study to Assess Safety, Tolerability, Pharmacokinetic & Pharmacodynamic Effect of UCB5857 in Healthy & Psoriatic Subject

Who this might be right for
Psoriasis
UCB Pharma 57
Not applicableStudy completedNCT04398732
What this trial is testing

Study to Evaluate the Efficacy of Enbrel as a Biological Treatment in Moderate to Severe Plaque Psoriasis Patients

Who this might be right for
Plaque Psoriasis
Pfizer 486
Post-approval studies (Phase 4)UnknownNCT00707070
What this trial is testing

Combining Acitretin and Efalizumab in the Therapy of Chronic Plaque Psoriasis

Who this might be right for
Chronic Plaque Psoriasis
Universita di Verona 100
Early research (Phase 1)Study completedNCT03542994
What this trial is testing

EDP1066 in Healthy Participants and Participants With Mild to Moderate Psoriasis and Atopic Dermatitis

Who this might be right for
PsoriasisAtopic Dermatitis
Evelo Biosciences, Inc. 114
Testing effectiveness (Phase 2)Study completedNCT01045577
What this trial is testing

A Double-blind, Placebo-controlled, Randomized, Parallel-group Study to Evaluate the Activity of Oral AB1010 in Adults Patients With Moderate to Severe Chronic Plaque Psoriasis

Who this might be right for
Psoriasis
AB Science 25
Not applicableStudy completedNCT00800982
What this trial is testing

Open Label Study Etanercept's Maintenance Dose in Obese Patients With Moderate to Severe Plaque Type Psoriasis

Who this might be right for
Psoriasis
University of California, San Francisco 30
Testing effectiveness (Phase 2)Study completedNCT05488990
What this trial is testing

Efficacy and Safety of Novel Formulations of Topical Calcipotriol in Patients With Mild to Moderate Plaque Psoriasis

Who this might be right for
Psoriasis Vulgaris
Lipidor AB 24
Testing effectiveness (Phase 2)Study completedNCT02785185
What this trial is testing

Safety and Efficacy of IDP-122 Lotion When Applied Topically to Subjects With Moderate to Severe Plaque Psoriasis

Who this might be right for
Psoriasis
Bausch Health Americas, Inc. 150
Testing effectiveness (Phase 2)Ended earlyNCT03329885
What this trial is testing

Experimental Medication BMS-986251, Taken by Mouth, in Healthy Participants and Patients With Average to Very Serious Psoriasis

Who this might be right for
Rheumatoid ArthritisPsoriasisAnkylosing Spondylitis+2 more
Bristol-Myers Squibb 38
Testing effectiveness (Phase 2)Active Not RecruitingNCT07290569
What this trial is testing

Dose Ranging Study of ORKA-001 in Patients With Moderate-to-Severe Plaque Psoriasis

Who this might be right for
Plaque Psoriasis
Oruka Therapeutics, Inc. 160
Large-scale testing (Phase 3)Study completedNCT05637515
What this trial is testing

Hulio Interchangeability to Humira®, Comparing Pharmacokinetics, Efficacy, Safety and Immunogenicity

Who this might be right for
Moderate Chronic Plaque PsoriasisSevere Chronic Plaque Psoriasis
Biocon Biologics Inc. 374
Testing effectiveness (Phase 2)Temporarily pausedNCT04121143
What this trial is testing

A Clinical Study of SHR-1314 Injection in the Treatment of Moderate to Severe Plaque Psoriasis in Adults

Who this might be right for
Plaque Psoriasis
Jiangsu HengRui Medicine Co., Ltd. 120
Not applicableLooking for participantsNCT06701513
What this trial is testing

A Real-world Study to Evaluate the Effectiveness of Deucravacitinib in Adults With Plaque Psoriasis in France (RePhlect)

Who this might be right for
Psoriasis
Bristol-Myers Squibb 350
Large-scale testing (Phase 3)Study completedNCT01947491
What this trial is testing

A Comparison of DFD01 Spray Versus Comp01 Lotion, Vehicle Spray and Vehicle Lotion in Subjects With Moderate Psoriasis

Who this might be right for
Psoriasis
Primus Pharmaceuticals 394
Large-scale testing (Phase 3)Study completedNCT00106834
What this trial is testing

The Safety and Efficacy of Infliximab in Patients With Psoriasis

Who this might be right for
Psoriasis
Centocor, Inc. 378
Early research (Phase 1)Study completedNCT02993471
What this trial is testing

Ixekizumab in Participants With Plaque Psoriasis

Who this might be right for
Psoriasis
Eli Lilly and Company 28
Testing effectiveness (Phase 2)Study completedNCT02235480
What this trial is testing

Efficacy and Safety of Tazarotene Gel in Nail Psoriasis

Who this might be right for
Nail Psoriasis
Almirall, S.A. 66
Post-approval studies (Phase 4)Not Yet RecruitingNCT07485764
What this trial is testing

Metformin Combined With Secukinumab for Moderate-to-Severe Plaque Psoriasis in Overweight or Obese Chinese Patients

Who this might be right for
PsoriasisPlaque PsoriasisModerate-to-severe Plaque Psoriasis+1 more
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 186
Testing effectiveness (Phase 2)Study completedNCT02180464
What this trial is testing

A Intra-individual Comparison to Investigate the Efficacy and the Safety of LAS41004 Formulation in Mild to Moderate Psoriasis

Who this might be right for
Psoriasis
Almirall, S.A. 40
Next Page